Patents by Inventor David W. Old

David W. Old has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic substituted piperidone compounds
    Patent number: 7994195
    Abstract: Compounds comprising or a pharmaceutically acceptable salt or a prodrug thereof are disclosed herein. Details are provided herein. Compositions, methods, and medicaments related thereto are also disclosed.
    Type: Grant
    Filed: November 2, 2005
    Date of Patent: August 9, 2011
    Assignee: Allergan, Inc.
    Inventors: David W. Old, Robert M. Burk
  • SUBSTITUTED CYCLOPENTANES OR CYCLOPENTANONES AS THERAPEUTIC AGENTS
    Publication number: 20110190301
    Abstract: Therapeutic compounds, methods, and compositions are disclosed herein for treating glaucoma and baldness in mammals. The specific compounds are described herein and are modified prostaglandin derivates.
    Type: Application
    Filed: May 13, 2009
    Publication date: August 4, 2011
    Applicant: ALLERGAN, INC.
    Inventors: David W. Old, Vinh X. Ngo, Todd S. Gac
  • THERAPEUTIC AGENTS FOR TREATMENT OF OCULAR HYPERTENSION
    Publication number: 20110184055
    Abstract: The invention provides well-defined amides for treating glaucoma and ocular hypertension.
    Type: Application
    Filed: January 21, 2011
    Publication date: July 28, 2011
    Applicant: ALLERGAN, INC.
    Inventors: David W. Old, Todd S. Gac
  • Therapeutic amides
    Patent number: 7985767
    Abstract: Compounds of the formula are disclosed herein. Therapeutic methods, compositions, and medicaments related thereto are also disclosed.
    Type: Grant
    Filed: September 6, 2007
    Date of Patent: July 26, 2011
    Assignee: Allergan, Inc.
    Inventors: David W. Old, Robert M. Burk, Todd S. Gac
  • Therapeutic substituted pyrroles
    Patent number: 7985765
    Abstract: Disclosed herein is a compound represented by a formula: Therapeutic methods, compositions, and medicaments related thereto are also disclosed.
    Type: Grant
    Filed: August 17, 2009
    Date of Patent: July 26, 2011
    Assignee: Allergan, Inc.
    Inventor: David W. Old
  • THERAPEUTIC COMPOUNDS
    Publication number: 20110178084
    Abstract: Compounds comprising or a pharmaceutically acceptable salt or a prodrug thereof are disclosed, wherein a dashed line represents the presence or absence of a bond; and, wherein Y, A, R, D, and n are as described. Methods, compositions, and medicaments related thereto are also disclosed.
    Type: Application
    Filed: May 13, 2009
    Publication date: July 21, 2011
    Applicant: ALLERGAN, INC.
    Inventors: David W. Old, Vinh X. Ngo
  • Therapeutic compounds
    Patent number: 7981887
    Abstract: Compounds comprising Formula (I) or a pharmaceutically acceptable salt thereof, are disclosed, wherein J1, J2, U1, B, Y, and A are as described. Methods, compositions, and medicaments related thereto are also disclosed, for treating glaucoma, inflammatory bowel disease and baldness.
    Type: Grant
    Filed: May 4, 2009
    Date of Patent: July 19, 2011
    Assignee: Allergan, Inc.
    Inventors: David W. Old, Vinh X. Ngo
  • THERAPEUTIC SUBSTITUTED CYCLOPENTANES
    Publication number: 20110172299
    Abstract: Disclosed herein are compounds represented by a formula: Therapeutic methods, compositions, and medicaments related thereto are also disclosed.
    Type: Application
    Filed: May 11, 2009
    Publication date: July 14, 2011
    Applicant: ALLERGAN, INC.
    Inventors: Todd Gac, David W. Old
  • Substituted gamma lactams as therapeutic agents
    Patent number: 7973071
    Abstract: A compound comprising or a pharmaceutically acceptable salt, prodrug, or a metabolite thereof is disclosed herein. Y, A, and B are as described herein. Methods, compositions, and medicaments related to these compounds are also disclosed.
    Type: Grant
    Filed: November 25, 2008
    Date of Patent: July 5, 2011
    Assignee: Allergan, Inc.
    Inventors: David W. Old, Danny T. Dinh
  • Combination Therapy For Glaucoma
    Publication number: 20110152328
    Abstract: Disclosed herein is method of treating glaucoma or ocular hypertension comprising administering a prostaglandin agonist and a second therapeutically active agent to a mammal in need thereof, wherein said second therapeutically active agent is selected from: ?-Blockers, Adrenergic Agonists, non-selective adrenergic agonists, ?2-selective adrenergic agonists, Carbonic Anhydrase Inhibitors, Cholinergic Agonists, direct acting cholinergic agonists, chlolinesterase inhibitors, Glutamate Antagonists, Ca2+ channel blockers, Prostamides, Prostaglandins, Cannabinoids, and combinations thereof. Compositions and medicaments containing a combination of these two active agents are also disclosed.
    Type: Application
    Filed: April 13, 2009
    Publication date: June 23, 2011
    Inventors: Scott M. Whitcup, Robert M. Burk, David W. Old, Yariv Donde, Wha-Bin Im, Mark A. Holoboski
  • Thiophenyl prostaglandin derivatives for treating glaucoma and ocular hypertension
    Patent number: 7964595
    Abstract: Disclosed herein is a compound according to one of the formulas wherein R is Additionally, pharmaceutically acceptable salt thereof, and methods of treating disease, medicaments, and compositions related thereto, are further elaborated herein.
    Type: Grant
    Filed: January 13, 2009
    Date of Patent: June 21, 2011
    Assignee: Allergan, Inc.
    Inventors: Brent A. Johnson, David W.. Old, Yariv Donde, Robert M. Burk
  • Therapeutic compounds
    Patent number: 7964596
    Abstract: Compounds comprising or a pharmaceutically acceptable salt or a prodrug thereof, are disclosed, wherein Y, A, B, and J are as described. Methods, compositions, and medicaments related thereto are also disclosed.
    Type: Grant
    Filed: February 27, 2009
    Date of Patent: June 21, 2011
    Assignee: Allergan, Inc.
    Inventors: David W. Old, Danny T. Dinh
  • Therapeutic compounds
    Patent number: 7960379
    Abstract: Compounds comprising or a pharmaceutically acceptable salt or a prodrug thereof, are disclosed, wherein J1, J2, B, Y, A and D are as described. Methods, compositions, and medicaments related thereto are also disclosed.
    Type: Grant
    Filed: March 12, 2009
    Date of Patent: June 14, 2011
    Assignee: Allergan, Inc.
    Inventors: David W. Old, Robert M. Burk
  • Thiophenyl prostaglandin derivatives for treating glaucoma and ocular hypertension
    Patent number: 7960431
    Abstract: Disclosed herein is a compound according to one of the formulas or a pharmaceutically acceptable salt thereof, medicaments for the treatment of glaucoma or ocular hypertension and compositions related thereto, as further elaborated herein.
    Type: Grant
    Filed: January 30, 2008
    Date of Patent: June 14, 2011
    Assignee: Allergan, Inc.
    Inventors: Brent A. Johnson, David W. Old, Yariv Donde, Robert M. Burk
  • Substituted gamma lactams as therapeutic agents
    Patent number: 7960381
    Abstract: A compound comprising or a pharmaceutically acceptable salt, prodrug, or a metabolite thereof is disclosed herein. Y, A, and B are as described herein. Methods, compositions, and medicaments related to these compounds are also disclosed.
    Type: Grant
    Filed: January 29, 2008
    Date of Patent: June 14, 2011
    Assignee: Allergan, Inc.
    Inventors: David W. Old, Wha-Bin Im
  • Substituted gamma lactams as therapeutic agents
    Patent number: 7956055
    Abstract: A compound having the formula or a pharmaceutically acceptable salt or a prodrug thereof is disclosed herein. Y, A, U, and B are as described herein. Methods, compositions, and medicaments related to these compounds are also disclosed.
    Type: Grant
    Filed: March 20, 2009
    Date of Patent: June 7, 2011
    Assignee: Allergan, Inc.
    Inventor: David W. Old
  • Therapeutic amides and related compounds
    Patent number: 7956051
    Abstract: Disclosed herein are compounds useful in treating glaucoma, inflammatory bowel disease, the stimulation of hair growth, and the stimulation of the conversion of vellus hair to terminal hair. The compounds themselves are herein.
    Type: Grant
    Filed: January 14, 2009
    Date of Patent: June 7, 2011
    Assignee: Allergan, Inc.
    Inventors: David W. Old, Danny T. Dinh
  • Therapeutic substituted chlorocyclopentanols
    Patent number: 7947732
    Abstract: Disclosed herein is a compound having a formula therapeutic methods, compositions, and medicaments related thereto are also disclosed.
    Type: Grant
    Filed: January 22, 2010
    Date of Patent: May 24, 2011
    Assignee: Allergan, Inc.
    Inventors: David W. Old, Vinh X. Ngo
  • THERAPEUTIC COMPOUNDS
    Publication number: 20110059939
    Abstract: Compounds comprising formula (I) or a pharmaceutically acceptable salt thereof, a dashed line represent the presence or absence of a double bond, are disclosed, wherein J1, J2, U1, B, Y, and A are as described in claims 1-12. Methods, compositions, and medicaments related thereto are also disclosed, for treating glaucoma, inflammatory bowel disease and baldness.
    Type: Application
    Filed: May 4, 2009
    Publication date: March 10, 2011
    Applicant: ALLERGAN ,INC
    Inventors: David W. Old, Vinh X. Ngo
  • THERAPEUTIC COMPOUNDS
    Publication number: 20110059967
    Abstract: Compounds comprising Formula (I) or a pharmaceutically acceptable salt thereof, are disclosed, wherein J1, J2, U1, B, Y, and A are as described in claims 1-16. Methods, compositions, and medicaments related thereto are also disclosed, for treating glaucoma, inflammatory bowel disease and baldness.
    Type: Application
    Filed: May 4, 2009
    Publication date: March 10, 2011
    Applicant: Allergan Inc.
    Inventors: David W. Old, Vinh X. Ngo